Claire Reiss, a major owner of Biocept, has just filed an initial statement of beneficial ownership where 14,012 shares of Biocept were declared. This form is usually filed as a prelude to receiving options or buying company shares, so there may be more to come from Reiss. Reiss operates out of San Diego, CA. Some additional info was provided as follows:
This amendment is being filed to include shares of Common Stock that were inadvertently omitted from the original Form 3 filing, as amended, and the subsequent Form 4 filing, as amended.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
General form for registration of securities under the Securities Act of 1933 - Nov. 21, 2017
General form for registration of securities under the Securities Act of 1933 - Nov. 17, 2017
Biocept Reports Third Quarter 2017 Financial Results - Nov. 9, 2017